Skip to content

What Makes a Cup, a Cup? Generalizing Novel Words

Technological Timescales: Identifying the Impact of Digital Media on the Mechanisms of Word Learning. Aim 2: What Makes a Cup, a Cup? Generalizing Novel Words

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05443399
Enrollment
212
Registered
2022-07-05
Start date
2022-04-07
Completion date
2025-04-30
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The goal of this work is to address increasing concerns about young children's digital media exposure and language outcomes by testing how the times course of word learning unfolds in digital environments and the cascading impact of digital media on vocabulary outcomes. The findings will have important implications for understanding when and where optimal word learning from media can occur.

Detailed description

The goal of the current proposal is to identify how digital media alters the mechanisms of word learning and subsequently impacts the lexical foundation on which a child's vocabulary is built. Specifically, the proposal aims to identify the impact of digital media on 1) the processes underlying real-time word learning, and 2) the processes of language generalization and vocabulary growth. Specific Aim 1 will use a novel word learning task to test children's ability to map and retain new words within and between digital media (2D images on a tablet) and real world objects (3D objects). Specific Aim 2 will probe children's novel label generalization abilities within and between 2D and 3D modalities using a novel noun generalization task. Further, individual differences in a child's prior technology experience will be measured and used to predict overall vocabulary as well as performance within and between each task. This Clinical Trial record focuses on Specific Aim 2.

Interventions

Modality in which items will be presented (via tablet/digital media or as real object). 3D items initially and generalization as 2D

Modality in which items will be presented (via tablet/digital media or as real object). 2D items initially and generalization as 3D

Modality in which items will be presented (via tablet/digital media or as real object). 2D items initially and generalization as 2D

Sponsors

Oklahoma State University
Lead SponsorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
17 Months to 30 Months
Healthy volunteers
Yes

Inclusion criteria

* between 18-30 months old

Exclusion criteria

* diagnosed developmental delay or disorder * exposure to more than 25% of another language

Design outcomes

Primary

MeasureTime frameDescription
Generalization Performance1 minuteAccuracy on selecting the target item on novel noun generalization task, defined as percent of choices to the shape-matching item across all trials

Countries

United States

Participant flow

Recruitment details

Recruitment occurred in Stillwater, OK and Dallas, TX through known channels, snowball, and social media efforts

Baseline characteristics

Characteristic
Age, Continuous23.94 age in months
STANDARD_DEVIATION 3.85
Ethnicity (NIH/OMB)
Hispanic or Latino
10 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
41 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
13 Participants
Race (NIH/OMB)
More than one race
3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants
Race (NIH/OMB)
White
33 Participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
34 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 00 / 00 / 0
other
Total, other adverse events
0 / 00 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 00 / 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026